defense anthrax
RSS defense anthraxSort by: Relevance | Date
U.S. Department of Defense: Unprecedented Pre-Clinical Research Acceleration to Find an Anthrax Treatment
White Paper The Anthrax project was launched when a key protein component of anthrax was submitted to the United Devices Global grid powered with the Grid MP platform. The team responsible for this collaborative... [03 Jul 2008]
Authorization of Emergency Use of Anthrax Vaccine Adsorbed for Prevention of Inhalation Anthrax by Individuals at Heightened Risk of Exposure Due to Attack With Anthrax; Availability
White Paper The Food and Drug Administration (FDA) is announcing the issuance of an Emergency Use Authorization (EUA) [the Authorization) for Anthrax Vaccine Adsorbed (AVA) for prevention of inhalation anthrax for... [15 Feb 2005]
Determination and Declaration Regarding Emergency Use of Anthrax Vaccine Adsorbed for Prevention of Inhalation Anthrax
White Paper The Secretary provides notice of the determination of the Department of Defense that there is a significant potential for a military emergency involving a heightened risk to United States military forces of attack with... [15 Feb 2005]
CSIS Homeland Defense: Asymmetric Warfare & Terrorism
White Paper An accidental release of an Anthrax agent in Sverdlovsk in Russia, in 1979, affected an area some three miles downwind from the factory and infected 80-200 Russians. This paper focuses on biological weapons. [28 Dec 2004]
Anthrax Attacks, Biological Terrorism and Preventive Responses
White Paper The United States and the former Soviet Union dedicated considerable national defense resources to their biological weapons programs, and both countries encountered significant difficulties along the way. [15 Feb 2005]
